Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of two dose levels of eicosapentaenoic acid on apoptosis and cell proliferation in colonic mucosa
2005-005634-12Phase 2Completed
- Sponsor
- SLA Pharma
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of eicosapentaenoic acid in colon adenoma (3 arms), sponsored by SLA Pharma. Primary endpoints: Within-patient change in proliferation and apoptosis markers at 3 months and Within-patient change in proliferation and apoptosis markers at 6 months. Started May 2006; status: completed.
02
Drugs
eicosapentaenoic acid
03
Conditions
colon adenoma
Beyond the preview
Go deeper on 2005-005634-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005634-12.